← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. Financial Ratios

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. Financial Ratios
  3. Quarterly

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. A
  3. Financial Ratios
  4. Quarterly
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets

Agilent Technologies, Inc. (A) Quarterly Financial Ratios

Last 47 quarters of trend data · Healthcare · Medical - Diagnostics & Research

← View 30-Year Annual Ratios

Valuation Multiples

Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.

Agilent Technologies, Inc.'s quarterly P/E stands at 31.3x, down 8.4% year-over-year. EV/EBITDA has expanded 10.8% YoY to 28.1x, reflecting rising market expectations or slowing EBITDA growth.

MetricTTMQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
P/E Ratio →25.9631.2723.9224.3235.8734.1326.7036.4432.6327.5615.9580.1133.19
—-8.4%-10.4%-33.3%+9.9%+23.8%+67.4%-54.5%-1.7%-13.7%-43.3%+162.9%+1.3%
P/S Ratio4.835.295.584.714.606.475.576.526.385.774.495.375.86
—-18.3%+0.2%-27.8%-28.0%+12.1%+24.2%+21.4%+9.0%-10.3%-19.5%-7.9%+4.9%
P/B Ratio5.005.506.175.145.007.226.436.976.466.185.186.466.96
—-23.7%-4.1%-26.3%-22.7%+16.7%+24.1%+7.9%-7.1%-23.2%-33.3%-17.9%-0.7%
P/FCF29.1554.3022.9931.5871.6532.5524.4328.5743.6424.2117.5318.6729.49
—+66.8%-5.9%+10.5%+64.2%+34.5%+39.4%+53.0%+48.0%-52.8%-35.7%-54.6%-28.0%
EV / EBITDA19.8928.0520.9820.0221.9025.3221.0526.7024.0821.8916.7245.8123.01
—+10.8%-0.3%-25.0%-9.1%+15.7%+25.9%-41.7%+4.7%-7.9%-15.3%+114.5%+8.1%
EV / EBIT23.77—22.9921.9528.2728.7223.1928.9727.5122.9717.7859.9126.05
——-0.9%-24.2%+2.8%+25.0%+30.4%-51.6%+5.6%-14.7%-20.8%+137.7%-2.0%

Profitability

Quarterly margins and returns. Watch for margin compression across consecutive quarters.

Agilent Technologies, Inc.'s operating margin was 19.6% in Q1 2026, down 4.2 pp QoQ and down 2.7 pp YoY.

Margins

MetricTTMQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
Gross Margin52.4%—51.8%52.6%51.9%53.5%53.9%54.2%54.4%54.8%54.2%39.4%53.8%
——-3.8%-2.9%-4.6%-2.3%-0.7%+37.7%+1.1%-0.7%-1.0%-28.0%+0.4%
Operating Margin21.3%19.6%23.8%20.7%18.0%22.4%24.0%21.1%23.1%23.2%24.2%8.0%22.3%
—-12.2%-0.8%-1.8%-22.1%-3.4%-0.8%+165.3%+3.5%-4.5%-5.1%-66.7%-0.4%
Net Margin18.8%17.0%23.3%19.3%12.9%18.9%20.6%17.9%19.6%21.0%28.1%6.6%17.6%
—-10.3%+13.0%+8.2%-34.2%-9.9%-26.7%+169.2%+11.3%+4.7%+41.4%-65.3%+3.2%

Return on Capital

MetricTTMQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
ROE20.6%4.5%6.6%5.4%3.5%5.3%5.9%4.7%5.0%5.8%8.3%2.0%5.3%
—-16.2%+11.3%+15.4%-28.8%-7.8%-28.6%+137.7%-6.3%-10.3%+17.7%-69.6%-0.6%
ROA10.6%2.4%3.5%2.8%1.8%2.7%3.1%2.6%2.8%3.2%4.4%1.0%2.8%
—-10.8%+13.2%+6.8%-36.8%-16.5%-30.6%+149.6%+1.6%-2.3%+26.5%-67.1%+5.5%
ROIC13.5%3.1%4.0%3.3%2.8%3.5%4.0%3.5%3.9%4.1%4.4%1.4%3.9%
—-10.3%-0.3%-6.6%-27.5%-14.8%-7.8%+153.9%-1.4%-7.5%-13.7%-69.0%-1.3%

Leverage & Debt

Quarterly solvency trend — watch for debt spikes or covenant pressure.

Agilent Technologies, Inc.'s Debt/EBITDA ratio is 9.5x, up from 6.5x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 6.0% YoY to 2.07x, tightening the short-term liquidity position. Debt/Equity has declined for 4 consecutive quarters, reflecting a deleveraging trend.

MetricTTMQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
Debt / Equity0.500.490.500.540.570.560.610.500.410.410.470.500.47
—-13.0%-17.9%+7.7%+38.5%+35.1%+29.5%-1.0%-13.0%-22.0%-10.4%-12.3%-16.6%
Debt / EBITDA1.909.506.537.899.377.517.497.406.005.735.8213.676.02
—+26.6%-12.9%+6.6%+56.2%+31.0%+28.8%-45.8%-0.3%-4.9%+14.3%+130.5%-8.4%
Current Ratio1.962.071.962.252.092.202.091.782.152.682.612.292.37
—-6.0%-6.3%+26.2%-2.6%-18.1%-20.0%-22.2%-9.4%+27.4%+28.6%+18.0%+18.0%
Quick Ratio1.521.591.521.711.601.661.581.371.642.041.971.681.71
—-4.3%-3.5%+24.8%-2.3%-18.6%-19.9%-18.4%-4.2%+33.4%+33.7%+19.3%+14.5%
Interest Coverage13.21—16.4112.8610.3413.4312.7515.1418.1517.4518.555.5415.96
—————————————

Download Financial Ratios Data

Includes 30+ ratios · 47 years · Updated daily

Full A Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

See A's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is A Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare with Peers

Compare business quality, growth, and profitability against top sector peers.

Start Comparison

A — Frequently Asked Questions

Quick answers to the most common questions about buying A stock.

What is Agilent Technologies, Inc.'s quarterly P/E ratio trend?

Agilent Technologies, Inc.'s current P/E is 26.0x. The average P/E over the last 4 quarters is 28.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.

How do Agilent Technologies, Inc.'s margins change by quarter?

Agilent Technologies, Inc.'s current operating margin is 21.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.

Why look at A quarterly ratios instead of annual?

Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Agilent Technologies, Inc.'s business trajectory between earnings reports.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.